Chris Markoch

Chris Markoch

Chris Markoch is a freelance financial writer who brings over 25 years in sales and marketing to help find the story behind the stock. Chris starts by asking the question, “So what?” and then uses fundamental and (some) technical analysis to add depth to that insight.

Stepping back from the “what” allows Chris to bring perspective that helps investors make wise decisions based on their risk tolerance and investing timeline.

Markoch would describe his writing as being for investors more than traders. He looks at equities through a long-term lens and that is reflected in his writing.

In addition to his articles on InvestorPlace, you can also find Chris’ writing on MarketBeat.com where he has collaborated on the e-book “5 Investing Trends That Will Define the Market in 2022.” You can find Chris on LinkedIn and on Twitter.

Recent Articles

What the Super Bowl Halftime Show Can Teach Investors About Palantir

Palantir had mixed earnings results. But part of the problem with PLTR stock may be because it's just not every investor’s thing.

Ocugen Stock Is a Fairy Tale in Need of a Happy Ending

If you’re investing in OCGN stock, you have to wonder: how much upside can FDA approval really give this beleaguered name?

7 Value Stocks to Buy in This Pricey Market

As it turns out, fundamentals still matter. Here are seven value stocks that you can buy confidently in this pricey market.

Crypto.com Will Make Sure You Know Its Name, Now Comes the Hard Part

Crypto.com coin continues to take steps to promote the mass adoption of crypto. But after it gets its message out the real work begins.

Sundial Growers Must Show Investors Things Are Better, Not Just Different

Sundial has more time to avoid delisting. But being granted extra time to avoid delisting isn't exactly a catalyst in any sense of the word.